Literature DB >> 23475663

Bioluminescent assays for cytochrome P450 enzymes.

Douglas S Auld1, Henrike Veith, James J Cali.   

Abstract

The cytochrome P450 (CYP) family contains 57 enzymes in humans. The activity of CYPs against xenobiotics is a primary consideration in drug optimization efforts. Here we describe a series of bioluminescent assays that enable the rapid profiling of CYP activity against compound collections. The assays employ a coupled-enzyme format where firefly luciferase is used to measure CYP enzyme activity through metabolism of pro-luciferase substrates.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23475663     DOI: 10.1007/978-1-62703-321-3_1

Source DB:  PubMed          Journal:  Methods Mol Biol        ISSN: 1064-3745


  3 in total

1.  Expanding biological space coverage enhances the prediction of drug adverse effects in human using in vitro activity profiles.

Authors:  Ruili Huang; Menghang Xia; Srilatha Sakamuru; Jinghua Zhao; Caitlin Lynch; Tongan Zhao; Hu Zhu; Christopher P Austin; Anton Simeonov
Journal:  Sci Rep       Date:  2018-02-28       Impact factor: 4.379

2.  Measurement of Human Cytochrome P450 Enzyme Induction Based on Mesalazine and Mosapride Citrate Treatments Using a Luminescent Assay.

Authors:  Young-Hoon Kim; Young-Ji Bae; Hyung Soo Kim; Hey-Jin Cha; Jae-Suk Yun; Ji-Soon Shin; Won-Keun Seong; Yong-Moon Lee; Kyoung-Moon Han
Journal:  Biomol Ther (Seoul)       Date:  2015-09-01       Impact factor: 4.634

3.  Discovery of New Chemical Tools against Leishmania amazonensis via the MMV Pathogen Box.

Authors:  Atteneri López-Arencibia; Ines Sifaoui; María Reyes-Batlle; Carlos J Bethencourt-Estrella; Desirée San Nicolás-Hernández; Jacob Lorenzo-Morales; José E Piñero
Journal:  Pharmaceuticals (Basel)       Date:  2021-11-24
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.